Company Ciprosyl Med Srl with Fiscal Code 18575613
recorded a turnover of 2024 of
396.128,
with a net profit of
18.541
and having an average number of employees of
12.
The company operates in the field of Alte activităţi referitoare la sănătatea umană n.c.a. having the NACE code 8699.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ciprosyl Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
103.221
115.519
137.696
148.125
186.472
225.379
351.325
362.531
412.542
396.128
Total Income - EUR
103.222
115.519
137.696
148.126
190.048
228.091
351.336
362.541
412.554
396.133
Total Expenses - EUR
96.302
111.595
123.841
143.306
163.967
203.415
283.828
312.088
362.252
365.708
Gross Profit/Loss - EUR
6.920
3.924
13.855
4.820
26.081
24.676
67.508
50.452
50.301
30.425
Net Profit/Loss - EUR
5.765
3.284
12.579
3.331
24.180
22.874
64.892
46.827
46.176
18.541
Employees
9
8
8
9
0
10
9
9
10
12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -3.4%, from 412.542 euro in the year 2023, to 396.128 euro in 2024.
The Net Profit decreased by -27.377 euro, from 46.176 euro in 2023, to 18.541 in the last year.
Check the financial reports for the company - Ciprosyl Med Srl
Financial Rating - CIPROSYL MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ciprosyl Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ciprosyl Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ciprosyl Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ciprosyl Med Srl - CUI 18575613
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
14.475
13.799
10.848
31.173
30.280
25.870
22.493
37.112
198.931
206.784
Current Assets
26.920
31.009
36.577
18.373
42.460
70.787
136.382
172.222
65.039
37.420
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
16.301
21.855
13.010
11.140
11.635
12.924
18.080
16.839
31.732
18.659
Cash
10.620
9.154
23.566
7.233
30.824
57.863
118.302
155.383
33.307
18.761
Shareholders Funds
27.981
30.980
43.035
45.575
68.873
90.441
149.923
197.215
242.793
259.978
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
13.415
13.828
4.452
4.207
4.099
6.445
9.174
12.353
21.550
85.220
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8699 - 8699"
CAEN Financial Year
8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
37.420 euro in 2024 which includes Inventories of
0 euro, Receivables of
18.659 euro and cash availability of
18.761 euro.
The company's Equity was valued at
259.978 euro, while total Liabilities amounted to
85.220 euro.
Equity increased by 18.542 euro, from 242.793 euro in 2023, to 259.978 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ciprosyl Med Srl